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Abstract
Background
Bone morphogenetic protein 4 (BMP4) signaling is involved in the development of Barrett’s
esophagus (BE), a precursor of esophageal adenocarcinoma (EAC). In various cancers,
BMP4 has been found to induce epithelial-mesenchymal transition (EMT) but its function in
the development of EAC is currently unclear.
Aim
To investigate the expression of BMP4 and several members of the BMP4 pathway in EAC.
Additionally, to determine the effect of BMP4 signaling in a human Barrett’s esophagus
(BAR-T) and adenocarcinoma (OE33) cell line.
Methods
Expression of BMP4, its downstream target ID2 and members of the BMP4 pathway were
determined by Q-RT-PCR, immunohistochemistry and Western blot analysis using biopsy
samples from EAC patients. BAR-T and OE33 cells were incubated with BMP4 or the
BMP4 antagonist, Noggin, and cell viability and migration assays were performed. In addi-
tion, expression of factors associated with EMT (SNAIL2, CDH1, CDH2 and Vimentin) was
evaluated by Q-RT-PCR andWestern blot analysis.
Results
Compared to squamous epithelium (SQ), BMP4 expression was significantly upregulated in
EAC and BE. In addition, the expression of ID2 was significantly upregulated in EAC and
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BE compared to SQ. Western blot analysis confirmed our results, showing an upregulated
expression of BMP4 and ID2 in both BE and EAC. In addition, more phosphorylation of
SMAD1/5/8 was observed. BMP4 incubation inhibited cell viability, but induced cell migra-
tion in both BAR-T and OE33 cells. Upon BMP4 incubation, SNAIL2 expression was signifi-
cantly upregulated in BAR-T and OE33 cells while CDH1 expression was significantly
downregulated. These results were confirmed by Western blot analysis.
Conclusion
Our results indicate active BMP4 signaling in BE and EAC and suggest that this results in
an invasive phenotype by inducing an EMT-like response through upregulation of SNAIL2
and subsequent downregulation of CDH1.
Introduction
Barrett’s esophagus (BE) is a premalignant condition in which the normal squamous epithe-
lium (SQ) is replaced by intestinal type of epithelium containing goblet cells.[1] BE is a well-
known risk factor for the development of esophageal adenocarcinoma (EAC). The incidence of
EAC is steeply increasing in the Western world [2] and the prognosis remains poor with 5-year
survival rates of 9% for metastatic and 25% for non-metastatic disease. [3] In the past decade
many genes with an aberrant expression pattern during the development of BE and EAC have
been reported. [4–6] However, understanding the cellular consequences of altered gene expres-
sion is far from complete.
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor β family
(TGF-β) and have multiple roles in cell proliferation, differentiation and migration. The BMP
family consists of more than 20 members each having their own BMP-receptor affinity and
regulating ligands. BMPs bind to transmembrane serine-threonine kinase receptors type 1 and
2 and activation of these receptors leads to phosphorylation of SMAD1, 5 and 8, which permits
binding to SMAD4. This complex translocates to the nucleus and regulates gene transcription
specific for the BMP pathway. Most of the functions of BMPs were thought to take place during
embryogenesis, but recent studies have shown that they are aberrantly expressed in various
malignancies and play a major role in cancer development. [7,8]
One of the BMPs, BMP4, is known to have an essential role in the development of BE.
Milano et al. reported that the BMP4 pathway was activated in inflamed epithelium of the
esophagus and in BE, in contrast to SQ were no active BMP4 signaling was found. [9,10] Zhou
et al. reported that after bile and acid exposure, BMP4 expression was upregulated in human
squamous epithelium cells. [11] Moreover, incubation of squamous cell cultures with BMP4
leads to a cytokeratin expression profile resembling that of BE. [9] This all suggests that in
reflux esophagitis, the BMP4 pathway is activated which can lead to an intestinal type epithe-
lium. [12] The molecular mechanism behind this metaplasic process is largely unknown; how-
ever, recent work of Mari et al. showed that binding of CDX2 and pSMAD 1/5/8 to the MUC2
promoter gene leads to the induction of MUC2 expression[13], which is one of the most char-
acteristic intestinal markers highly expressed in BE. [10]
During the malignant progression from BE to EAC, oncogenes and tumor supressor genes
are differently expressed leading to acquisition of invasive characteristics and eventually to
metastasis. In the past, several studies have reported the ability of BMP4 to induce SNAIL2
expression. [14–20] SNAIL2 is one of the transcription factors regulating epithelial-mesenchymal
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transition (EMT). This transdifferentiation process results in cellular detachment from the base-
ment membrane and controls cell motility. [21] Cells which have undergone EMT will express
stromal keratins i.e. Vimentin. In cancer, cells most frequently de-differentiate rather than trans-
differentiate showing an EMT like response. [22] A limited number of studies have focused on
the role of EMT and/or an EMT-like response in relation to the malignant progression from BE
to EAC. [23–25]
Until now, studies regarding the expression of BMP4 and the effect of BMP4 signaling in
EAC are limited. We hypothesized that BMP4 could play a role in the progression from BE to
EAC by inducing an EMT-like response. Therefore, we determined the expression of BMP4
and several members of the BMP4 pathway in EAC and investigated the effect of BMP4 signal-
ing in a human Barrett’s esophagus (BAR-T) and an esophageal adenocarcinoma (OE33) cell
line.
Materials and Methods
Biopsy specimens
Between September 2009 and May 2013, SQ, BE and EAC biopsy specimens were obtained
from patients with BE associated EAC. Patient characteristics are shown in Table 1. Biopsies
were collected during routine endoscopy and immediately frozen in liquid nitrogen and stored
at -80°C. Pairwise-taken control biopsies were obtained to confirm the histological diagnosis.
Patients were not treated with neoadjuvant chemotherapy and/or radiotherapy prior to biopsy
sampling. All patients used proton pump inhibitor therapy. This study was approved by the
Medical Ethics Committee of the University Medical Center Utrecht. All patients signed
informed consent.
Table 1. Patient characteristics of biopsies used for Western blot, IHC and Q-RT-PCR analysis.
Number Sex Age (Years) TNM stage
EAC 1 M 59 T3N4 WB and IHC
EAC 2 M 49 T3N2 WB and Q-RT-PCR
EAC 3 M 73 T2N0 WB, IHC and Q-RT-PCR
EAC 4 M 65 T2N0 WB, IHC and Q-RT-PCR
EAC 5 M 80 T2N1 WB, IHC and Q-RT-PCR
EAC 6 M 42 T3N1 WB, IHC and Q-RT-PCR
EAC 7 M 81 T1N0 IHC
EAC 8 M 57 T1N1M0 IHC
EAC 9 M 68 T2N0M0 IHC
EAC 10 F 39 T3N0M0 IHC
EAC 11 M 67 T3N1 IHC
EAC 12 M 69 T3N1M1a IHC
EAC 13 M 69 T3N0M0 IHC
EAC 14 M 72 T4N1M1a IHC and Q-RT-PCR
EAC 15 M 61 T2N0 Q-RT-PCR
EAC 16 M 79 T3N2 Q-RT-PCR
EAC 17 M 70 T3N1M0 Q-RT-PCR
EAC 18 M 47 T3N1M1a Q-RT-PCR
M = male, F = female, WB = Western blot, IHC = Immunohistochemistry, Q-RT-PCR = Quantitative Real Time PCR.
doi:10.1371/journal.pone.0155754.t001
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RNA isolation and Quantitative Reverse Transcriptase Polymerase
Chain Reaction (Q-RT-PCR)
Total RNA from biopsy specimens was extracted using RNA easy isolation kit, while total RNA
from cell culture experiments was extracted using miRNeasy Mini kit (both Qiagen, Venlo, the
Netherlands), according to the manufacturer’s instructions. RNA concentrations were measured
using Nanodrop technology (Thermo Scientific, Erembodegem-Aalst, Belgium); all samples had
an excellent 260/280 ratio. cDNA synthesis and Q-RT-PCR reactions were performed as previ-
ously described. [26] Primer sequences and annealing temperatures are shown in Table 2. Taq-
man assays (Applied Biosystems, Forster City, CA, USA) were used to measure the expression of
BMPR1a (Hs01034913_g1), BMPR1b (Hs00176144_m1), BMPR2 (Hs00176148_m1) and
SNAIL2 (Hs00950344_m1). Expression of the reference genes GAPDH (Hs4333764F) and B2M
(Hs4333766F) were used for normalization.
Relative expression was calculated using the ΔCt method. [27] All reactions were performed
in duplicate. Data were expressed relative to SQ biopsies, control cells or cells incubated with
Noggin.
Western blot analysis
Protein samples were extracted using cell lysis buffer (Cell Signaling, Boston, MA, USA) con-
taining 1% protease inhibitor (Sigma, St Louis, MO, USA). Cell lysates were centrifugated at
maximum speed for 5 minutes at 4°C and the pellet was discarded. The lysates were diluted in
protein sample buffer (100mM Tris pH 6.8, 2% β-mercaptoethanol, 4% SDS, 0.2% bromphenol
blue, 20% glycerol) and incubated at 95°C for 5 min. Samples were loaded onto a 10%
SDS-PAGE gel and subsequently transferred onto a PVDF membrane (Millipore, Amsterdam,
the Netherlands). The blots were blocked with Odyssey Blocking buffer (Westburg, Leusden,
the Netherlands) diluted 1:1 in Tris buffered saline (TBS) and subsequently washed with TBS.
Blots were incubated 30–60 minutes at room temperature or overnight at 4°C with the primary
antibody (Table 3) in Odyssey Blocking buffer diluted 1:1 in TBS supplemented with 0.1%
Tween-20. After washing, blots were incubated with Alexa Fluor 680 conjugated secondary
antibody (Invitrogen, Bleiswijk, the Netherlands) for 1 hour at room temperature. Visualiza-
tion was performed using an Odyssey scanner (Westburg).
Immunohistochemistry
Four μm tissue sections were deparaffinized and blocked for endogeneous peroxidase activity
by immersion in 0.3% H2O2 in methanol for 20 minutes. Antigen retrieval was performed in
Table 2. Primer sequences.
Target Forward primer Reverse primer Annealing temperature (°C)
BMP4 TGAGCCTTTCCAGCAAGTTT CTTCCCCGTCTCAGGTATCA 57.5
SMAD1 CACAAACATGATGGCGCCT CATAGTAGACAATAGAGCACCAGTGTTT 58
SMAD4 TCCCGGACATTACTGGCCTGTTCA GCGATCTCCTCCAGAAGGGTCCA 57.5
SMAD5 TTCTGGCTCAATCTGTCAACC GGAGCCATCTGAGTAAGGAC 57.5
ID2 ACTCGCATCCCACTATTGTC CGTCCATTCAACTTGTCCTCC 60
CDH1 CGAGAGCTACACGTTCACGG GGGTGTCGAGGGAAAAATAGG 58
CDH2 TGGGAATCCGACGAATGG TGCAGATCGGACCGGATACT 58
Vimentin GGAAGCCGAAAACACCCTG GAGACGCATTGTCAACATCCT 58
Primer sequences used for Q-RT-PCR with corresponding annealing temperature
doi:10.1371/journal.pone.0155754.t002
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Tris/EDTA buffer (10 mM/1mM; pH 9.0) for 20 minutes at 100°C. After cooling for 10 min-
utes and washing in PBS pH 7.4, nonspecific binding sites were blocked with Serum Free Pro-
tein Block (Dako, Glostrup, Denmark) for 10 minutes followed by 1 hour incubation with
SMAD4 antibody (Santa Cruz technology, Santa Cruz, CA, USA) at room temperature. Anti-
body binding was visualized using the BrightVision poly-HRP detection system (Immunologic,
Duiven, the Netherlands) with 3,3-diamino-benzidine as chromogen. Sections were counter-
stained using hematoxylin, dehydrated and coverslipped using Pertex. Pancreas cancer tissue
sections were used as negative control, showing no SMAD4 staining [28]. Control slides in
which the primary antibody was omitted, were included. All sections were evaluated using a
binocular microscope (Olympus BX 51, Zoeterwoude, the Netherlands).
Cell culture
The human telomerase-immortalized non-neoplastic Barrett epithelium cell line, BAR-T [29]
was kindly provided by Dr. R.F. Souza and cultured in Keratinocyte basal medium-2 (Lonza,
Breda, the Netherlands), as described by Jaiswal et al. [29] Cell culture experiments were per-
formed in collagen IV-coated wells (BD Biosciences, San Jose, CA, USA). The human esoph-
ageal adenocarcinoma cell line, OE33 (ECACC, Porton Down, Salisbury, United Kingdom)
was cultured in RPMI-1640 with L-glutamine medium (Invitrogen) supplemented with 10%
fetal bovine serum (FBS; Glico, Bleiswijk, the Netherlands) and 100 U/ml penicillin (Invitro-
gen) and 100 μg/ml streptomycin (Invitrogen). To evaluate the effect of BMP4 signaling, cells
were seeded and after overnight attachment, the medium was replaced with serum reduced
medium (0.2% FBS). Cells were incubated with 100 ng/ml recombinant human BMP4 or with
500 ng/ml Noggin Fc Chimera (both from R&D Systems, Minneapolis, MN, USA). All experi-
ments were performed in duplicate and repeated at least 3 times.
Cell viability
Cell viability was measured using MTT-assay (ATCC, Manassas, VA, USA), according to the
manufacturer’s instructions. After 24 and 48 hours of incubation, colorimetric analysis was
Table 3. Antibodies used for Western blot analysis.
Protein Company Dilution
BMP4 R&D Systems Minneapolis, Minnesota, USA 1:1000
BMPR1a (ALK-3) R&D Systems Minneapolis, Minnesota, USA 1:500
BMPR1b (ALK-6) R&D Systems Minneapolis, Minnesota, USA 1:400
BMPR2 R&D Systems Minneapolis, Minnesota, USA 1:1000
SMAD1 Cell Signaling Technology, Danvers,
Massachusetts, USA
1:1000
SMAD4 (B-8) Santa Cruz Biotechnology, Santa Cruz,
California, USA
1:1000
pSMAD 1/5/8 (Ser463/465 Ser463/465
Ser426/428)
Cell Signaling Technology, Danvers,
Massachusetts, USA
1:1000
ID2 (C-20) Santa Cruz Biotechnology, Santa Cruz,
California, USA
1:1000
SNAIL2 (C19G7) Cell Signaling Technology, Danvers,
Massachusetts, USA
1:1000
CDH1 BD Biosciences, San Jose, California, USA 1:2000
Actin (I-19) Santa Cruz Biotechnology, Santa Cruz,
California, USA
1:2000
doi:10.1371/journal.pone.0155754.t003
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performed at 570 nm (reference 655 nm; Molecular Devices, Sunnyvale, CA, USA). All experi-
ments were performed in duplicate and repeated at least 3 times.
Cell migration
In vitro scratch assays were performed to evaluate cell migration; cells were seeded in a 12-well
plate and after 24 hours scratched with a 10 μl pipette tip to create an artificial wound. Cells
were washed twice with PBS to remove cellular debris and fresh medium was added. After 24
hours photographs of the scratches were taken. Images of the areas were taken using an EVOS
microscope (Westburg).
To confirm our results from the scratch assays, Boyden chamber migration assays were per-
formed. BAR-T cells suspended in serum free medium with BMP4 or Noggin were plated in
the upper part of a 24-well, 8-μm pore, cell migration chamber (Cell biolabs inc, San Diego,
CA, USA) according to the manufacturer’s protocol. Medium with 10% FBS was placed in the
lower wells as chemotactic stimulus. Cells were allowed to migrate for 24 hours in a 37°C incu-
bator with 5% CO2. Optical density of the dye was measured at 560 nm in a 96-well microtiter
plate (Molecular Devices). All experiments were performed in duplicate and repeated at least 3
times.
Statistical analysis
Data were analyzed using GraphPad Prism version 6.02 (San Diego, CA, USA). mRNA expres-
sion from biopsy specimens were presented as box plots, comparisons between different dis-
ease states were calculated using unpaired Student’s t-test or Mann-Withney U test when
appropriate. The Mann-Withney U test was used to evaluate the effect of incubation with
BMP4 or Noggin on ID2 expression in both BAR-T and OE33 cells. In all other cell culture
experiments, data were expressed as mean ± standard deviation (SD) or standard error of the
mean (SEM) and comparisons between groups were calculated using a Wilcoxon test. To
exclude the effect of any active BMP4 signalling in control cells on mRNA expression, the
results of cell culture experiments were compared to cells incubated with Noggin instead of
control cells. A p-value of< 0.05 was considered statistically significant.
Results
Active BMP4 signaling in BE and EAC
To determine whether there is active signaling in BE and EAC, expression of BMP4, molecules
involved in the BMP4 signaling pathway and its downstream target, ID2, were determined in
SQ, BE and EAC biopsy specimens by Q-RT-PCR (Fig 1a). BMP4 was 11.2-fold (p = 0.001)
upregulated increased in EAC and 8.9-fold (p< 0.0001) upregulated in BE compared to SQ.
The downstream target, ID2, was significantly upregulated in both EAC (3.2-fold, p = 0.002)
and BE (3.5-fold, p = 0.02) compared to SQ. Of the BMP receptors, BMPR1b was significantly
upregulated in EAC compared to BE and SQ (both p = 0.02). In contrast, SMAD1 was 2.2-fold
(p = 0.008) downregulated in EAC and 1.8-fold (p = 0.02) downregulated in BE compared to
SQ. SMAD5 was 2.6-fold (p = 0.04) downregulated in BE compared to SQ. BMP receptors
BMPR1a, BMPR2 and SMAD4 were all expressed and were not found to be statistically differ-
ent between the various groups (Fig 1a).
Next to mRNA expression, we determined protein expression levels by Western blot analy-
sis. Upregulated expression of BMP4 and ID2 were observed in both BE and EAC (Fig 1b). In
BMP4 in Barrett's Esophagus and Esophageal Adenocarcinoma
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addition, more activation of pSMAD1/5/8 was observed in BE and EAC. In contrast, SQ did
not show BMP4, and ID2 expression or pSMAD1/5/8 activation.
SMAD4 is often aberrantly expressed in malignancies and we therefore determined SMAD4
expression in EAC biopsy specimens using immunohistochemistry (Fig 1C). Eleven of 13 EAC
specimens showed diffuse SMAD4 expression in both the nucleus and cytoplasm. The other 2
EAC specimens showed no SMAD4 expression. SMAD4 expression was present in 9 of 13 and
10 of 13, SQ and BE biopsy specimens respectively. Similar to EAC, BE specimens showed dif-
fuse SMAD4 expression in both the nucleus and cytoplasm. In contrast, SQ specimens showed
nuclear SMAD4 expression in the basal cells adjacent to the basement membrane, however no
SMAD4 expression was observed in the more mature epithelial cells of the superficial layers
(Fig 1C).
Fig 1. Expression of BMP4, BMP4 pathway associatedmolecules and the downstream target ID2. a.
Q-RT-PCR was used to determine mRNA expression of BMP4, its downstream target, ID2, BMP4 associated
receptors and SMADmolecules in SQ, BE and EAC biopsy specimens. B2M and GAPDH were used for
normalization. Data are relative to the mean ΔCt of SQ biopsies and are expressed as box plots, representing
the mean with the minimum and maximum values. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. b.
Western blot analysis in SQ, BE and EAC biopsy specimens showed BMP4, and ID2 expression and
phosphorylation of SMAD1/5/8 in BE and EAC. Actin was used as loading control. Biopsy samples from 6
EAC patients were used. Representative pictures are shown. c. IHC showed nuclear and cytoplasmic
expression of SMAD4 in 10 of 13 BE (arrowhead) and 11 out of 13 EAC tissue sections. EAC* represents a
biopsy specimen with positive SMAD4 staining, EAC** represents a biopsy specimen with negative SMAD4
staining, stromal cells are SMAD4 positive and serve as internal control. Haematoxylin counterstain was
used. Representative pictures are shown.
doi:10.1371/journal.pone.0155754.g001
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In vitro BMP4 signaling showed a decrease in cell viability and an
increase in migration in both a BE and EAC cell line
As a control, we first determined ID2 expression in BAR-T and OE33 cells upon BMP4 and
Noggin incubation. Q-RT-PCR results showed a significantly upregulated ID2 expression in
cells incubated with BMP4. A significant downregulation of ID2 expression was observed in
cells incubated with Noggin compared to control cells. This effect was confirmed by Western
blot analysis which also showed more phosphorylation of SMAD1/5/8 (Fig 2).
To explore the functional effect of BMP4 incubation in BAR-T and OE33 cells, cell viability
and migration assays were performed. The results of the cell viability assays can be found in the
supplementary data (S1 Fig).
Results from the scratch assays showed an increase in cell migration in both BAR-T and
OE33 cells upon BMP4 incubation compared to cells incubated with Noggin and control cells
(Fig 3a). These results were confirmed by a Boyden chamber assay for BAR-T cells; after 24
hours we observed a significant increase in cell migration in cells incubated with BMP4 com-
pared to cells incubated with Noggin, 132% (±24.5) versus 84% (± 6.3; p = 0.006) respectively
(Fig 3b).
Fig 2. ID2 expression upon BMP4 or Noggin incubation. a. mRNA expression of the downstream target
ID2. B2M was used for normalization. Data are relative to the mean ΔCt of control cells and are expressed as
mean±SEM. *p<0.05, **p<0.01, ***p<0.001. b. Western blot analysis of BAR-T and OE33 cells incubated
with BMP4 showed upregulated ID2 expression and more phosphorylation of SMAD1/5/8. Cells incubated
with Noggin showed downregulated ID2 expression. Actin was used as loading control.
doi:10.1371/journal.pone.0155754.g002
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Upregulated SNAIL2 expression upon BMP4 incubation in BE and EAC
cells
EMT is an important contributor in regulating cell motility and to assess the consequences of
BMP4 signaling in both BE and EAC, we investigated the ability of BMP4 signaling to induce
EMT in BAR-T and OE33 cell lines. Q-RT-PCR was used to determine SNAIL2 expression, a
transcription factor regulating EMT, in BAR-T and OE33 cells incubated with BMP4. BAR-T
cells incubated with BMP4 for 24 hours showed a significant upregulation of SNAIL2 with a
1.6 (1.58±0.20; p = 0.02) fold induction compared to BAR-T cells incubated with Noggin.
OE33 cells incubated with BMP4 showed a 3.7 (3.71±0.46; p = 0.02) fold induction of SNAIL2
after 24 hours and a 2.3 (2.31±0.44; p = 0.02) fold induction after 48h (Fig 4a). These results
were confirmed by Western blot analysis, which showed upregulated SNAIL2 expression in
BMP4 incubated BAR-T and OE33 cells (Fig 4b).
Next, we determined factors associated with EMT regulated by SNAIL2. CDH1, which is
directly inhibited by SNAIL2, did not show a significant difference in mRNA expression in
Fig 3. Migration assays of BAR-T and OE33 cells upon incubation with BMP4 or Noggin. a. In vitro
scratch assay of BAR-T and OE33 cells. The rate of migration across the scratched area was monitored for
24 h. Representative images showed that the scratch induced cells incubated with BMP4 to migrate
compared to control cells or cells incubated with Noggin. Images are representative of three independent
experiments. b. Boyden chamber assay of BAR-T cells incubated with BMP4 or Noggin. Data are relative to
control cells not incubated with BMP4 or Noggin and expressed as mean ±SD. * p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0155754.g003
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BAR-T (1.87±0.36) and OE33 cells (0.77±0.16) after 24 hours. However, after 48 hours, CDH1
expression was significantly (1.4 fold, 0.69±0.11; p = 0.02) downregulated in BAR-T cells incu-
bated with BMP4 compared to cells incubated with Noggin. OE33 cells showed a tendency to
CDH1 downregulation upon BMP4 incubation that was borderline significant (1.4 fold, 0.69
±0.11; p = 0.06). Upon a one-tailed Wilcoxon test, CDH1 downregulation upon BMP4 incuba-
tion was statistically significant (p = 0.03). These results were confirmed byWestern blot analy-
sis, showing downregulation of CDH1 in cells incubated with BMP4 compared with cells
incubated with Noggin after 48 and 72 hours (Fig 4b).
Mesenchymal markers, CDH2 and Vimentin did not show any significant difference after
24 and 48 hours. However, after 72 hours upon incubation with BMP4 in BAR-T cells, a strong
tendency to upregulated mRNA expression of both CDH2 (7.85±7.89; p = 0.09) and Vimentin
(4.68±6.78; p = 0.06) was seen. OE33 cells incubated with BMP4 showed also upregulation of
mRNA of CDH2 (2.98±4.25) and Vimentin (2.27±2.92), although this was not statistically sig-
nificant. We were not able to evaluate CDH2 and Vimentin protein expression in both BAR-T
and OE33 cell culture experiments due to technical problems. As the positive control showed
CDH2 and Vimentin expression, we concluded that it is likely that CDH2 and Vimentin
expression in BAR-T and OE33 cells is very low.
Discussion
BMP4 is known to play an important role in the development of BE in the esophagus. [9,13,
26] However, little is known about the expression and function of the BMP4 pathway in the
neoplastic development towards EAC. In this study, we showed active BMP4 signaling in EAC
biopsy specimens (Fig 1). We subsequently studied the functional role of BMP4 signaling in
Fig 4. mRNA and protein expression of factors associated with EMT upon BMP4 or Noggin
incubation. a. Q-RT-PCR was performed to determine mRNA expression of SNAIL2 and its target genes,
CDH1, CDH2 and Vimentin. B2M was used for normalization. Data are relative to the mean ΔCt of cells
incubated with Noggin and are expressed as mean±SEM. *p<0.05. b. Western blot analysis of BAR-T and
OE33 cells showed that SNAIL2 expression was upregulated and CDH1 expression was downregulated in
cells incubated with BMP4 compared to cells incubated with Noggin. Actin was used as loading control.
Pictures are representative of three independent experiments.
doi:10.1371/journal.pone.0155754.g004
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BAR-T and OE33 cell lines and found that BMP4 signaling decreased cell viability and
increased cell migration (Fig 3). Furthermore, upregulated SNAIL2 expression was found in
BAR-T and OE33 cells upon incubation with BMP4. CDH1, a known target of SNAIL2, was
found to be downregulated. (Fig 4)
BMP4 is aberrantly expressed in many cancers. [7] In most cases there is an upregulated
BMP4 expression compared with the corresponding normal tissue, for example in renal cell
carcinoma, gastric cancer and squamous cell carcinoma originating in the head and neck
region. [30–32] Previously, BMP4 expression was observed in both EAC and esophageal squa-
mous cell carcinoma. [4] However, until now active BMP4 signaling was not confirmed in
EAC. Here, we demonstrated expression of essential members of the BMP4 pathway in SQ, BE
and EAC tissue. In addition we showed upregulation of BMP4, and, its downstream target ID2
in both BE and EAC tissue. Moreover more phosphorylation of SMAD1/5/8 was observed.
This together with the fact that both cytoplasmic and nuclear SMAD4 staining was observed in
BE and EAC suggests active BMP4 signaling in BE and EAC.
In epithelial neoplasms, cells are required to gain motile properties in order to metastasize, a
process called EMT. Epithelial cells lose their cell-junctions and cell-extracellular matrix con-
nections, reorganize their cytoskeleton and reprogram gene expression, which leads to a more
invasive mesenchymal phenotype. EMT is not only important for cancer metastasis but also
plays a major role in embryogenesis, wound healing and fibrosis. [33] The hallmarks of EMT
are the downregulation of CDH1 and the upregulation of CDH2, Vimentin and α-smooth
muscle actin. The process of EMT is controlled by transcription factors including SNAIL,
TWIST and ZEB. [21] SNAIL2 is a transcriptional repressor and directly binds to the
E2-homeobox promotor region of CDH1 leading to CDH1 downregulation. Additionally,
through indirect mechanisms, SNAIL2 activates the expression of mesenchymal genes such as
Vimentin and CDH2. [34]
The exact consequences of increased BMP4 signaling are not completely understood. How-
ever, the functional effects of active BMP4 signaling have been investigated in vitro in various
cancer cell lines, showing the possibility of a tumor-specific reaction upon BMP4 activation.
[7] For example, in pancreatic and ovarian cancer increased migration and decreased cell
growth has been observed, while in brain tumors increased cell growth and in breast cancer
reduced cell growth was demonstrated upon BMP4 incubation. [7] Recently, several studies
have shown the ability of BMP4 to induce EMT or an EMT like response during embryogenesis
[14,15], wound healing [16,17] and in various cancer cell lines [18–20]. In vitro cultured ovar-
ian and pancreatic cancer cells showed upregulation of SNAIL2 and downregulation of CDH1
upon BMP4 incubation. [18,20] Gordon et al. also showed that BMP2, BMP4 and BMP7 were
able to induce EMT in a pancreatic cancer cell line. [35] Our results showed that BMP4 is able
to de-differentiate BE and EAC cells by upregulating SNAIL2 and subsequently downregulat-
ing CDH1 expression leading to a more invasive cell. In line with the results of Theriault et al.
[18], the downregulation of CDH1 occurred after 48 hours of BMP4 incubation. Our results
showed a tendency of CDH2 mRNA upregulation but we did not observe any effect on the
expression of Vimentin. This may be explained by the fact that both CDH2 and Vimentin are
no direct but indirect targets of SNAIL2 [21]. In addition, other transcription factors i.e.
SNAIL1 or TWIST may also be important to completely induce EMT. Moreover, morphologi-
cal changes take place concurrently with upregulated expression of mesenchymal markers and
other studies observed morphological changes after 3–7 days. [17,18,20] Extending the experi-
ments up to 72 hours, might induce morphological changes and upregulate the expression of
mesenchymal markers in the esophagus. This is the first study focusing on the role of BMP4
signaling on an EMT like response and we believe that future studies are needed to fully eluci-
date this.
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Previous studies investigating EMT in EAC have shown expression of the transcription fac-
tors SNAIL1, SNAIL2 and TWIST. [23] Rees et al. reported upregulation of mesenchymal
genes, Vimentin and α-smooth muscle actin, and downregulation of CDH1 at the invasive
margins of EAC compared to the central tumor using immunohistochemistry. [24] A study by
Jethwa et al. concluded that SNAIL2 was upregulated in EAC compared to BE and SNAIL2
expression was inversely correlated with CDH1 expression. In addition, overexpression of
SNAIL2 in OE33 cells resulted in downregulation of CDH1. [25] Previous studies have indi-
cated that during malignant progression from BE to EAC, the expression of CDH1 is downre-
gulated, which is known to be associated with a worse prognosis. [36–39] In addition to these
studies, we showed that active BMP4 signaling resulted in downregulation of CDH1. In theory,
active BMP4 signaling could be associated with a worse prognosis. In the future, manipulation
of the BMP4 pathway may help to prevent neoplastic progression in BE patients.
In summary our study showed that the BMP4 signaling pathway, which is highly expressed
and activated in BE and EAC, is capable of de-differentiating epithelial cells to an EMT like
response in the esophagus through an upregulation of SNAIL2 and subsequently a downregu-
lation of CDH1. In combination with the previous described literature, our study suggests that
BMP4 signaling could induce malignant progression from BE to EAC. However, further stud-
ies are required to explore the precise molecular role of BMP4 activation in the esophagus.
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